daytrades march 3 morning ..., page-11

cdy annc:

Sydney, 4 March 2010: Cellmid (ASX:CDY) today signed research, development and collaboration agreements with Pharmahungary for the pre-clinical and early clinical validation programs for midkine to treat heart attack (acute myocardial infarction or AMI).


Well that's a relieve if u bought at high
n feel some acute myocardial infarction

Here's a better release:
KayaRaya inc annc validation programs for
heart attack prevention:
*5 veg n 2 fruits
*Exercise
*DYOR

LOL

K R
No Pain No Gain bumper sticker issuer.